Table 3.
Averages and changes in maximum daily AQHI values during 2016–2019 and lockdown Phases 2–3 by monitoring site within the MCMA.
| Period | Site | 2016–2019 | Lockdown | ΔAQHIa |
|---|---|---|---|---|
| Phase 2 | UBS | 15 | 16 | 1 |
| UBN | 17 | 16 | −1 | |
| TRA | 17 | 16 | −1 | |
| RES | 18 | 15 | −3*** | |
| IND | 19 | 16 | −3** | |
| COM | 19 | 16 | −3* | |
| Average | 17 | 15 | −2* | |
| Phase 3 | UBS | 18 | 12 | −6*** |
| UBN | 18 | 16 | −2*** | |
| TRA | 20 | 15 | −5*** | |
| RES | 21 | 15 | −6*** | |
| IND | 22 | 16 | −6*** | |
| COM | 22 | 17 | −5*** | |
| Average | 19 | 15 | −4*** |
a
Levels of significance determined with the non-parametric Wilcoxon test.
*
Level of significance p < 0.05.
**
Level of significance p < 0.01.
***
Level of significance p < 0.001.